Nanoscope Awarded Key U.S. Patent Protecting its Multi-Characteristic Opsin Gene Therapy Platform For Reversing Blindness

/PRNewswire/ -- Nanoscope Therapeutics Inc, a clinical-stage biotechnology company developing optogenetic gene therapies for retinal degenerative diseases,...

Related Keywords

Australia ,Japan ,Bedford ,Texas ,United States ,Sulagna Battacharya ,Samarendra Mohanty ,Dan Eramian ,Drug Administration ,Opus Biotech Communications ,Nanoscope Therapeutics Inc ,Multi Characteristic Opsin ,Multi Characteristic Opsins ,Nanoscope Therapeutics ,